For severe allergic asthma: omalizumab,1 for eosinophilic asthma: anti-IL5/anti-IL5 receptor treatment,2, 3, 4 and for asthma with type 2 inflammation: dupilumab.5 The gene discussed is IL5; the disease is allergic asthma.